Core Insights - Itron reported a revenue of $571.66 million for the quarter ended December 2025, reflecting a year-over-year decline of 6.7% while EPS increased to $2.46 from $1.35 in the same quarter last year, exceeding the Zacks Consensus Estimate for EPS by 12.55% [1] Revenue Performance - Revenue from Outcomes was $111.83 million, surpassing the four-analyst average estimate of $98.38 million, with a year-over-year increase of 22.6% [4] - Revenue from Device Solutions was $104.83 million, slightly above the average estimate of $95.82 million, but showed a year-over-year decline of 3.4% [4] - Revenue from Networked Solutions was $351.95 million, below the estimated $366.53 million, representing a year-over-year decrease of 14.8% [4] - Service revenues from Networked Solutions reached $29.09 million, exceeding the average estimate of $24.5 million, with a year-over-year increase of 13.1% [4] - Product revenues from Device Solutions were $104.18 million, above the average estimate of $96.46 million, but down 3% year over year [4] - Product revenues from Networked Solutions were $322.86 million, below the estimated $339.58 million, reflecting a year-over-year decline of 16.7% [4] - Total product revenues were $474.33 million, slightly below the average estimate of $480.12 million, with a year-over-year decrease of 10.9% [4] - Service revenues from Outcomes were $64.54 million, exceeding the average estimate of $60.15 million, with a year-over-year increase of 20.5% [4] - Service revenues from Device Solutions were $0.65 million, below the estimated $1.09 million, showing a significant year-over-year decline of 43.9% [4] - Total service revenues were $97.33 million, surpassing the average estimate of $85.75 million, with a year-over-year increase of 21% [4] - Product revenues from Outcomes were $47.29 million, exceeding the average estimate of $38.97 million, with a year-over-year increase of 25.8% [4] Stock Performance - Itron's shares have returned -10.7% over the past month, compared to a -1.4% change in the Zacks S&P 500 composite, indicating potential underperformance in the near term with a Zacks Rank of 4 (Sell) [3]

Core Viewpoint - Analysts expect Itron (ITRI) to report quarterly earnings of $2.19 per share, reflecting a year-over-year increase of 62.2%, while revenues are projected to be $561.79 million, down 8.3% from the previous year [1] Earnings Projections - The consensus EPS estimate has been revised down by 0.4% over the past 30 days, indicating a collective reassessment by analysts [1][2] - The average estimates for key metrics include a projected 'Revenue- Outcomes' of $98.38 million, indicating a year-over-year change of +7.9% [4] - 'Revenue- Device Solutions' is expected to be $95.82 million, reflecting a decline of 11.7% from the year-ago quarter [4] - 'Revenue- Networked Solutions' is forecasted to reach $366.53 million, suggesting a year-over-year decrease of 11.3% [4] Revenue Breakdown - The consensus estimate for 'Service Revenue- Networked Solutions' stands at $24.50 million, indicating a year-over-year change of -4.8% [5] - 'Product Revenue- Device Solutions' is expected to be $96.46 million, down 10.2% from the prior-year quarter [5] - 'Product Revenue- Networked Solutions' is projected to be $339.58 million, reflecting a decline of 12.4% from the previous year [6] - Total Product Revenue is estimated to be $480.12 million, indicating a year-over-year decrease of 9.8% [6] Profit Expectations - Analysts predict 'Gross Profit- Device Solutions' will reach $28.12 million, compared to $28.83 million reported in the same quarter last year [8] - 'Gross Profit- Outcomes' is expected to be $40.34 million, slightly up from $40.10 million reported in the previous year [8] Market Performance - Over the past month, Itron shares have recorded a return of +6.3%, contrasting with the Zacks S&P 500 composite's -0.3% change [8] - Based on its Zacks Rank 4 (Sell), ITRI is expected to underperform the overall market in the upcoming period [8]

Core Viewpoint - InfuSystem Holdings, Inc. will participate in the 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025, showcasing its role as a leading national healthcare service provider [1][11]. Company Overview - InfuSystem Holdings, Inc. operates as a national healthcare service provider, facilitating outpatient care for durable medical equipment manufacturers and healthcare providers [3]. - The company utilizes a two-platform model: - **Patient Services**: This segment includes Oncology, Pain Management, and Wound Therapy, focusing on the last-mile solution for clinic-to-home healthcare [3]. - **Device Solutions**: This segment supports Patient Services and includes direct payer rentals, pump and consumable sales, and biomedical services and repair [3]. - InfuSystem is headquartered in Rochester Hills, Michigan, and operates Centers of Excellence in multiple states and Ontario, Canada [3]. Conference Participation - Carrie Lachance, President and CEO, and Barry Steele, CFO, will represent InfuSystem at the conference, which will be held at the Sheraton New York Times Square Hotel [1][2]. - The company will host in-person one-on-one meetings throughout the day for interested investors [2].

Core Insights - Itron reported revenue of $581.63 million for Q3 2025, a year-over-year decline of 5.5%, with EPS at $1.54 compared to $1.84 a year ago, indicating a slight surprise over estimates [1] - The revenue exceeded the Zacks Consensus Estimate of $576.45 million by 0.9%, while the EPS surpassed the consensus estimate of $1.48 by 4.05% [1] Revenue Breakdown - Device Solutions revenue was $103.62 million, below the average estimate of $111.07 million, reflecting a year-over-year decline of 15.6% [4] - Networked Solutions revenue reached $393.7 million, slightly above the average estimate of $383.53 million, with a year-over-year decline of 5.5% [4] - Outcomes revenue was $84.3 million, exceeding the average estimate of $82.67 million, showing a year-over-year increase of 10.9% [4] - Total Product Revenue was $494.32 million, below the average estimate of $499.62 million, representing an 8.2% decline year-over-year [4] - Total Service Revenue was $87.3 million, surpassing the average estimate of $77.03 million, with a year-over-year increase of 13.1% [4] Performance Metrics - Itron's shares returned +12.9% over the past month, outperforming the Zacks S&P 500 composite's +3.6% change [3] - The company holds a Zacks Rank 2 (Buy), suggesting potential for outperformance in the near term [3]

Core Viewpoint - InfuSystem Holdings, Inc. is set to release its third quarter 2025 financial results on November 4, 2025, before the market opens, followed by a conference call to discuss these results [1][2]. Company Overview - InfuSystem Holdings, Inc. is a leading national health care service provider that facilitates outpatient care for durable medical equipment manufacturers and health care providers [4]. - The company operates under a two-platform model: - The first platform, Patient Services, focuses on providing last-mile solutions for clinic-to-home healthcare, particularly in Oncology, Pain Management, and Wound Therapy [4]. - The second platform, Device Solutions, supports Patient Services and includes direct payer rentals, pump and consumable sales, and biomedical services and repair [4]. - InfuSystem is headquartered in Rochester Hills, Michigan, and has Centers of Excellence in multiple states and Ontario, Canada [4].

Core Insights - Itron reported revenue of $606.76 million for the quarter ended June 2025, a decrease of 0.4% year-over-year, with an EPS of $1.62, up from $1.21 in the same quarter last year [1] - The revenue fell short of the Zacks Consensus Estimate of $609.26 million, resulting in a surprise of -0.41%, while the EPS exceeded the consensus estimate of $1.33 by 21.8% [1] Revenue Breakdown - Device Solutions revenue was $112.76 million, slightly below the average estimate of $113.1 million, reflecting a year-over-year decline of 4.9% [4] - Outcomes revenue reached $85.07 million, compared to the average estimate of $85.73 million, marking a year-over-year increase of 9.3% [4] - Networked Solutions revenue totaled $408.93 million, below the average estimate of $411.45 million, with a year-over-year change of -0.9% [4] Service and Product Revenue - Service Revenue from Networked Solutions was $29.45 million, exceeding the average estimate of $24.94 million, with a year-over-year increase of 16.2% [4] - Total Service Revenue amounted to $89.58 million, surpassing the average estimate of $77.61 million, reflecting a year-over-year growth of 17.6% [4] - Total Product Revenue was $517.18 million, below the average estimate of $531.86 million, indicating a year-over-year decline of 3% [4] Gross Profit and Performance Metrics - Gross Profit for Device Solutions was reported at $33.59 million, exceeding the average estimate of $30.33 million [4] - Itron's shares returned +3.2% over the past month, outperforming the Zacks S&P 500 composite's +2.7% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Core Insights - Itron, Inc. reported solid second quarter results with record levels of margin, profitability, and cash flow despite macroeconomic uncertainties [1][2] - Total revenue for the second quarter was $607 million, slightly down from $609 million in the prior year, reflecting a catch-up of previously constrained revenue [2][8] - The company experienced a 5% decrease in Device Solutions revenue, while Outcomes revenue increased by 9% due to higher recurring revenue and software licenses [3][8] Revenue Breakdown - Device Solutions revenue decreased by 5%, or 8% in constant currency, primarily due to lower legacy electricity product sales [3] - Networked Solutions revenue saw a 1% decrease compared to the second quarter of 2024, attributed to the timing of shipments and project deployments [3] - Outcomes revenue increased by 9%, driven by increased recurring revenue and software licenses [3] Profitability Metrics - Gross margin for the second quarter was 36.9%, an increase of 230 basis points from the prior year, attributed to product and customer mix [4] - GAAP operating income rose to $76 million, a $12 million increase from the prior year, while non-GAAP operating income increased by $13 million to $82 million [5] - Net income attributable to Itron, Inc. was $68 million, or $1.47 per diluted share, compared to $51 million, or $1.10 per diluted share in 2024 [6] Cash Flow and Backlog - Net cash provided by operating activities was $97 million, up from $52 million in the prior year, with free cash flow increasing to $91 million from $45 million [8][9] - Total backlog at the end of the quarter was $4.5 billion, compared to $4.1 billion in the prior year, with bookings totaling $454 million [10] Outlook - The company updated its outlook for the full year 2025, projecting revenue between $2.35 billion and $2.4 billion and non-GAAP diluted EPS between $6.00 and $6.20 [14]

Core Insights - Itron, Inc. reported financial results for Q1 2025, showing margin expansion and earnings growth ahead of expectations due to a favorable product mix and strong execution [1][2][4] Revenue Performance - Total revenue for Q1 2025 increased by 1% to $607 million, including a catch-up of previously constrained revenue from Q1 2024 [2] - Device Solutions revenue decreased by 1%, but increased by 2% in constant currency, driven by higher smart water sales offset by lower legacy electricity sales [2] - Networked Solutions revenue also decreased by 1% due to shipment timing and project deployment delays [3] - Outcomes revenue increased by 14%, attributed to higher recurring revenue and software licenses [3] Profitability Metrics - Gross margin for Q1 2025 was 35.8%, an increase of 180 basis points from the previous year, due to product mix and operational efficiencies [4] - GAAP operating income rose to $76 million, a $13 million increase from the prior year, while non-GAAP operating income also increased by $13 million to $80 million [5] Net Income and Earnings Per Share - Net income attributable to Itron, Inc. for the quarter was $65 million, or $1.42 per diluted share, compared to $52 million, or $1.12 per diluted share in 2024 [6] - Non-GAAP net income was $70 million, or $1.52 per diluted share, up from $57 million, or $1.24 per diluted share in the previous year [7] Cash Flow and Backlog - Net cash provided by operating activities was $72 million, compared to $41 million in the prior year, while free cash flow increased to $67 million from $34 million [8][9] - Total backlog at the end of the quarter was $4.7 billion, up from $4.3 billion in the prior year, with bookings totaling $530 million [10]